Get the full Ondine Biomedical Inc. company profile
Access contacts, investors, buying signals & more
Ondine Biomedical Inc. has raised $13.3M in new funding. The life sciences company is developing photodisinfection-based therapies aimed at preventing and treating serious infections, including those caused by antimicrobial-resistant pathogens.
Ondine's patented platform technology is designed to address complex infections across different therapeutic areas in both healthcare and industry settings. The company says its approach targets existing, emerging, and resistant pathogens alike.
Ondine raises £10m to advance US approval plans for infection treatment Ondine raises £10m to advance US approval plans for infection treatment Ondine Biomedical has raised £10m to support its bid for US approval of a light-activated nasal treatment designed to reduce infections after surgery .
The Canadian life sciences company, listed on London’s AIM market, said the funding would support regulatory work and expand use of its Steriwave technology in countries where it is approved. The fundraising follows results from a phase 3 trial involving 5,188 surgical patients. Ondine reported a 40.5 per cent lower risk of surgical site infections within 30 days compared with standard care, based
Specific Biologics
Specific Biologics' mission is to develop novel gene editing technologies to treat diseases at the genetic level in cells inside the body. We are actively developing a platform technology consisting of a dual-cleaving nuclease that can be safely delivered to cells for the treatment of various genetic diseases. This technology is designed to better exploit the cell's naturally occurring DNA repair pathways through enhanced repair or predictable deletions.
$35.0M Series a
today
Bloomsco Inc.
Bloomsco develops software and provides support for military training development. Based in Montréal, Canada, the company helps defence organizations build and update training tailored to their units, turning source documents into military training analysis and drafts for expert review.
$711.0K Pre-seed
5 days ago
Largest funding rounds in Healthcare on Signalbase right now.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Kismet Australia | Pre-seed | $42.0B | 2y ago |
| 2 |  Johnson & Johnson United States | Unknown | $7.0B |
Companies that recently closed a Unknown round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Metalkas S.A. Poland | Unknown | $25.3M | today |
| 2 | ViridiCO2 Ltd. United Kingdom | Unknown | $2.9M | today |
North Vector Dynamics
North Vector Dynamics is a Canadian-owned and controlled defence technology company specializing in precision interception, autonomy, and advanced propulsion. NVD is building a full-spectrum missile capability, from counter-UAS solutions to hypersonics, designed to serve and defend NATO member states and their allies and partners. Backed by leading Canadian, American and European defence tech investors, NVD is led by a team of experienced engineers, scientists, and operators with experience in academia, NASA, and the Canadian Armed Forces. As a trusted partner of defence primes and systems integrators, NVD is quickly establishing itself as a venture-backed defence technology innovator.
$20.0M Series a
8 days ago
| 2y ago |
| 3 |  Inari Medical United States | Unknown | $4.9B | 1y ago |
| 4 |  MultiPlan United States | Unknown | $4.5B | 1y ago |
| 5 |  Edwards Lifesciences United States | Unknown | $4.2B | 1y ago |
| 3 |
 Rise Of Fearless |
| Unknown |
| $1.0M |
| today |
| 4 |  ironlattice United States | Unknown | $3.0M | today |
| 5 |  Quint Computing Germany | Unknown | $10.1M | today |
Contacts, investors, buying intent signals & tech stack.
Trusted by 200+ sales teams
See who invested in Ondine Biomedical Inc. and reach their contacts directly.
Start free trial
Rosarium Health
Recently received
Aíma
Recently received
Stride
Recently received
